Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

10.990
-0.110-0.99%
Volume:4.36M
Turnover:47.93M
Market Cap:28.22B
PE:17.45
High:11.100
Open:11.180
Low:10.960
Close:11.100
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:0.75
T/O Rate:0.17%
Dividend:0.21
Dividend Rate:1.91%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.57
PE(LYR):17.45
PS:2.77

Loading ...

Simcere Pharmaceutical - DR. Zhou Will Serve as President

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million

THOMSON REUTERS
·
Aug 20

Simcere Pharma Surges Nearly 5% in Morning Trading as Huatai Retains Buy Rating

Deep News
·
Aug 20

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Stock News
·
Aug 20

Earning Preview: SIMCERE PHARMA this quarter’s revenue is expected to increase by 27%, and institutional views are bullish

Earnings Agent
·
Aug 13

Simcere Pharma Sets 20 Aug 2026 Board Meeting to Review 1H26 Results and Possible Interim Dividend

Bulletin Express
·
Aug 10

Simcere Pharma Sets Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 10

Simcere Pharmaceutical Group (SEHK:2096) Guidance Puts Valuation Back In Focus

Simply Wall St.
·
Aug 10

Simcere Pharmaceutical Expects 1H 2026 Revenue of Rmb4,550 Million-RMB4,610 Million

Reuters
·
Jul 30

Simcere Expects 1H Revenue up 27%-29% to RMB 4.55-4.61 Billion

Reuters
·
Jul 30

Simcere Pharma issues profit alert: 1H 2026 revenue to rise nearly 29 %, net profit up to RMB 860 million

Bulletin Express
·
Jul 30

Simcere Pharmaceutical - Expects 1H 2026 Revenue of Rmb4,550 Mln-RMB4,610 Mln, up 26.9%-28.6%

THOMSON REUTERS
·
Jul 30

Simcere Pharmaceutical - Sees Profit Attributable Rmb810 Mln to Rmb860 Mln for 1H 2026

THOMSON REUTERS
·
Jul 30

Movement Alert|SIMCERE PHARMA Falls 5.29% in Regular Trading, Trading at 12.2 HKD

Market Focus
·
Jul 30

Strategic AI Partnership Fuels Innovation and Pipeline Expansion for SIMCERE PHARMA

Stock News
·
Jul 15

SIMCERE PHARMA Partners with Global AI Drug Design Leader Schrödinger, Leveraging Dual "Physics+AI" Tech to Reshape Innovative Drug Pipeline Valuation

Stock News
·
Jul 10

Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List

MT Newswires Live
·
Jul 09

Simcere Pharma’s SANBEXIN® Added to China’s 2026 National Essential Medicines List

Bulletin Express
·
Jul 09

SIMCERE PHARMA's Novel Stroke Treatment Included in National Essential Medicines List

Stock News
·
Jul 09